Orbitofrontal neurons acquire responses to 'valueless' Pavlovian cues during unblocking

  1. Michael A McDannald
  2. Guillem R Esber
  3. Meredyth A Wegener
  4. Heather M Wied
  5. Tzu-Lan Liu
  6. Thomas A Stalnaker
  7. Joshua L Jones
  8. Jason Trageser
  9. Geoffrey Schoenbaum  Is a corresponding author
  1. National Institute on Drug Abuse, United States
  2. University of Pittsburg, United States
  3. University of Maryland School of Medicine, United States
  4. National Taiwan University, Taiwan
  5. Johns Hopkins University, United States

Abstract

The orbitofrontal cortex (OFC) has been described as signaling outcome expectancies or value. Evidence for the latter comes from the studies showing that neural signals in the OFC correlate with value across features. Yet features can co-vary with value, and individual units may participate in multiple ensembles coding different features. Here we used unblocking to test whether OFC neurons would respond to a predictive cue signaling a 'valueless' change in outcome flavor. Neurons were recorded as the rats learned about cues that signaled either an increase in reward number or a valueless change in flavor. We found that OFC neurons acquired responses to both predictive cues. This activity exceeded that exhibited to a 'blocked' cue and was correlated with activity to the actual outcome. These results show that OFC neurons fire to cues with no value independent of what can be inferred through features of the predicted outcome.

Article and author information

Author details

  1. Michael A McDannald

    National Institute on Drug Abuse, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Guillem R Esber

    National Institute on Drug Abuse, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Meredyth A Wegener

    University of Pittsburg, Pittsburg, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Heather M Wied

    University of Maryland School of Medicine, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Tzu-Lan Liu

    National Taiwan University, Taipei, Taiwan
    Competing interests
    The authors declare that no competing interests exist.
  6. Thomas A Stalnaker

    National Institute on Drug Abuse, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Joshua L Jones

    University of Maryland School of Medicine, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Jason Trageser

    Johns Hopkins University, Baltimore, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Geoffrey Schoenbaum

    National Institute on Drug Abuse, Baltimore, United States
    For correspondence
    geoffrey.schoenbaum@nih.gov
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Animal experimentation: Rats were tested at the University of Maryland School of Medicine and the NIDA-IRP in accordance with SOM and NIH guidelines (12-CNRB-108).

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 2,039
    views
  • 199
    downloads
  • 54
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Michael A McDannald
  2. Guillem R Esber
  3. Meredyth A Wegener
  4. Heather M Wied
  5. Tzu-Lan Liu
  6. Thomas A Stalnaker
  7. Joshua L Jones
  8. Jason Trageser
  9. Geoffrey Schoenbaum
(2014)
Orbitofrontal neurons acquire responses to 'valueless' Pavlovian cues during unblocking
eLife 3:e02653.
https://doi.org/10.7554/eLife.02653

Share this article

https://doi.org/10.7554/eLife.02653

Further reading

    1. Neuroscience
    Takashi Yamamoto, Kayoko Ueji ... Shinya Ugawa
    Research Article

    The concept of ‘kokumi’, which refers to an enhanced and more delicious flavor of food, has recently generated considerable interest in food science. However, kokumi has not been well studied in gustatory physiology, and the underlying neuroscientific mechanisms remain largely unexplored. Our previous research demonstrated that ornithine (L-ornithine), which is abundant in shijimi clams, enhanced taste preferences in mice. The present study aimed to build on these findings and investigate the mechanisms responsible for kokumi in rats. In two-bottle preference tests, the addition of ornithine, at a low concentration that did not increase the favorability of this substance alone, enhanced the animals’ preferences for umami, sweet, fatty, salty, and bitter solutions, with the intake of monosodium glutamate showing the most significant increase. Additionally, a mixture of umami and ornithine synergistically induced significant responses in the chorda tympani nerve, which transmits taste information to the brain from the anterior part of the tongue. The observed preference enhancement and increase in taste-nerve response were abolished by antagonists of the G-protein-coupled receptor family C group 6 subtype A (GPRC6A). Furthermore, immunohistochemical analysis indicated that GPRC6A was expressed in a subset of type II taste cells in rat fungiform papillae. These results provide new insights into flavor-enhancement mechanisms, confirming that ornithine is a kokumi substance and GPRC6A is a novel kokumi receptor.